T J Qin

ORCID: 0009-0008-9082-5394 · 2 papers in corpus · active 2019-2021

Study types

  • article 2
article 2021
[Prognostic factors of cyclosporine A combined with danazol with or without thalidomide in myelodysplastic syndrome treatment with low-percentage bone marrow blasts].
·doi:10.3760/cma.j.issn.0253-2727.2021.05.005

CsA combined with danazol with or without thalidomide regimen could improve cytopenia symptoms in patients with MDS with low-percentage bone marrow blasts. At age <60 years, no transfusion dependence of RBC and wild-type U2AF1 mutation is a…

article 2019
[Ruxolitinib combined with prednisone, thalidomide and danazol for treatment of myelofibrosis: a pilot study].
·doi:10.3760/cma.j.issn.0253-2727.2019.01.005

RUX combined with PTD for treatment of MF may modulate initial hematologic toxicity observed when RUX alone, and may increase response due to improved levels of hemoglobin or platelet.